E84.1 Cystic fibrosis with intestinal manifestations

Name of the Condition

• Cystic Fibrosis with Intestinal Manifestations (ICD-10 Code: E84.1)

Summary

Cystic fibrosis with intestinal manifestations is a subtype of cystic fibrosis characterized by digestive and gastrointestinal complications. It involves the production of thick, sticky mucus that obstructs pancreatic ducts and intestines, leading to malabsorption, bowel obstruction, and other intestinal issues. This condition requires targeted management to address nutritional deficiencies and prevent intestinal complications.

Causes

Cystic fibrosis with intestinal manifestations is caused by mutations in the CFTR (cystic fibrosis transmembrane conductance regulator) gene, which disrupts the regulation of salt and water movement in cells. These mutations result in defective CFTR protein function, leading to abnormal mucus production in the digestive tract. The disorder follows an autosomal recessive inheritance pattern, meaning an individual must inherit two copies of the mutated gene (one from each parent) to develop the condition.

Risk Factors

• Family history of cystic fibrosis.
• Being of Northern European descent (higher prevalence).
• Carrying one copy of the CFTR mutation (carrier status).

Symptoms

• Greasy, bulky stools or difficulty with bowel movements.
• Poor weight gain or growth despite adequate nutrition.
• Intestinal blockage (meconium ileus in newborns).
• Abdominal pain or distension.
• Rectal prolapse (in severe cases).
• Fatty or foul-smelling stools.

Diagnosis

Diagnosis involves a combination of clinical evaluation, genetic testing for CFTR mutations, and specialized tests. Newborn screening may detect elevated immunoreactive trypsinogen (IRT) levels, followed by sweat chloride testing to confirm high salt concentrations. Stool analysis may show fat malabsorption, and imaging (e.g., abdominal X-rays) can identify intestinal blockages. Genetic testing confirms the presence of CFTR mutations.

Treatment Options

Treatment focuses on managing intestinal symptoms and nutritional deficiencies. Pancreatic enzyme replacement therapy (PERT) improves nutrient absorption. High-calorie, high-fat diets with fat-soluble vitamin supplements address malnutrition. Medications like laxatives or mucolytics may relieve bowel obstructions. In severe cases, surgery may be required to address intestinal complications.

Prognosis and Follow-Up

Prognosis depends on the severity of intestinal involvement and adherence to treatment. Regular follow-up with gastroenterologists and dietitians is essential to monitor growth, nutritional status, and intestinal health. Early intervention can improve outcomes, but complications like bowel obstruction or malnutrition may require ongoing management.

Complications

• Intestinal blockage or obstruction.
• Malnutrition or growth failure.
• Rectal prolapse.
• Liver disease (in some cases).
• Bowel inflammation or strictures.

Lifestyle & Prevention

• Follow a high-calorie, high-fat diet with enzyme supplements.
• Stay hydrated to prevent dehydration from malabsorption.
• Avoid foods that worsen gastrointestinal symptoms.
• Engage in regular physical activity to support digestion.
• Attend routine medical appointments for monitoring.

When to Seek Professional Help

Seek immediate medical attention for severe abdominal pain, vomiting, or inability to pass stool, as these may indicate intestinal obstruction. Consult a healthcare provider for persistent diarrhea, unexplained weight loss, or signs of malnutrition.

Tips for Medical Coders

Document the presence of intestinal manifestations (e.g., malabsorption, bowel obstruction) to support the E84.1 code. Include details on diagnostic tests (e.g., sweat chloride, genetic testing) and treatments (e.g., PERT, dietary modifications) to clarify the clinical basis for coding. Ensure documentation aligns with the specific intestinal complications reported.